MENU
XPH
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS
SPDR® S&P Pharmaceuticals ETF (XPH) Ownership - Who owns SPDR® S&P Pharmaceuticals ETF?
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U... Show more
Category: #Health
Profile
Category
Health
Address
SPDR Series TrustOne Lincoln Street Cph0326Boston
Phone
N/A
Web
www.spdrs.com
Details
Group
Domestic Stock Funds
Category
Health
Net Assets
139922260.00
Fund Existence
almost 19 years
Turnover
61.00
Capitalization
N/A
Yield
1.50
Total Expense Ratio
0.35
Investment Style
N/A
Risk (Beta)
0.74
Fundamentals
XPH
Net Assets
140M
Yield
1.50
Fund Existence
almost 19 years
Total Expense Ratio
0.35
Turnover
61.00
Investment Style
N/A
Capitalization
N/A
Risk (Beta)
0.74
Manager Tenure
N/A
Administrative Fee
N/A
Annual Report Gross Expense Ratio
0.35
Assets in Top Ten Holdings
95.6M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
140M
Fund Type
ETF
Index Fund
Yes
Management Fee
0.35
Modified Duration
N/A
No Load Fund
Yes
Number of Long Holdings
46.00
Number of Net Holdings
46.00
Number of Short Holdings
N/A
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
42.34%
Gain YTD
-8.497
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Category Health
Profile
Fundamentals
Details
Category
Health
Address
SPDR Series TrustOne Lincoln Street Cph0326Boston
Phone
N/A
Web
www.spdrs.com